Advanced Finance

Contingent Value Rights

When buyer and seller cannot agree what an asset is worth, the deal can pay for it later if it works. Learn how to price that promise, and why most of the disputes are about effort rather than about the milestone.

  • Expert
  • 12 min total
  • 13 chapters

What decision this helps you make: Whether to bridge a valuation gap with a contingent payment, how to value one you have been offered, and what has to be in the agreement for the promise to be worth anything.

What this topic is

A contingent value right is a contractual right to receive additional consideration if a specified future event occurs - a regulatory approval, a sales threshold, a litigation outcome, or a share price level. It is issued as part of merger consideration alongside cash or stock. It may be transferable and listed, or non-transferable and held only by the shareholders of record at closing.

Why it matters

In pharmaceutical and biotechnology acquisitions, the difference between buyer and seller views of a pipeline asset is often larger than the entire agreed price. A contingent value right lets the parties close the deal now and settle the disagreement with the facts later. It also creates one of the most litigated relationships in corporate law, because the party who controls whether the milestone is achieved is the party who has to pay if it is - and the contractual standard governing that conflict is a phrase like commercially reasonable efforts, which means whatever the agreement says it means.

Who should learn it

Corporate development and M&A professionals, biotech founders and boards facing an acquisition, transaction lawyers, valuation practitioners marking contingent consideration, and event-driven investors who trade listed contingent value rights.

What you will understand

  • How to value a milestone payment correctly, and why the usual high discount rate is a double count
  • The difference between transferable and non-transferable structures and what each costs
  • How efforts covenants are drafted, how courts have read them, and where the drafting actually protects the holder
  • The accounting and tax mechanics that determine what each side reports, and where the answers are fact-specific

Prerequisites

Common misconception

The intuitive way to value a contingent value right is to take the payout, apply a probability, and then discount at a high rate because the whole thing is risky. That double counts. The scientific and regulatory risk is already in the probability, and it is idiosyncratic - a diversified investor holding many such claims is not compensated for risk they can diversify away. The correct discount rate for a milestone-driven payment is close to the payer's own credit-adjusted borrowing rate, because once the milestone occurs, the payment is an ordinary unsecured obligation of the acquirer. Applying a venture-style discount rate on top of a probability weighting can understate the value by half or more.